NCT00824317View on ClinicalTrials.gov

Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
ADHD
Interventions
DRUG

methylphenidate

(15 mg daily), medium (25 mg daily) and high (40 mg daily)

DRUG

Placebo

Trial Locations (1)

10029

Mount Sinai School of Medicine, New York

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT00824317 - Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type | Biotech Hunter | Biotech Hunter